Ribbon Cutting Ceremony on Wednesday, June 14 ANDERSON, S.C., June 9, 2023 /PRNewswire/ — The Blood Connection is celebrating World Blood Donor Day with the grand opening of its newest donation center in Anderson, SC. The center is now open at 101 Hanna Crossing in Anderson, SC – across from T.L. Hanna High School. A ribbon … Read more
SAN DIEGO, June 8, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Thursday, June 15, 2023 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) in Dana Point, CA. Kevin Gorman, Chief Executive Officer, and Matt Abernethy, Chief Financial Officer, will present at … Read more
CARLSBAD, Calif., June 7, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today the pricing of $500.0 million aggregate principal amount of 1.75% Convertible Senior Notes due 2028 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities … Read more
SCOTTSDALE, Ariz., June 7, 2023 /PRNewswire/ — A1 Group, Inc. (the “Company” or “AWON”) would like to announce that it has upgraded its services with OTC Markets, Inc. (“OTC Markets”) to provide Level 2 Quote Data to the public. The Company has paid the annual fee to OTC Markets to allow for real-time, two-sided complete … Read more
NEW YORK, June 7, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce that the Company has appointed Sandra Pennell as its new Senior Vice President of Finance. Ms. Pennell will also serve … Read more
Durable remissions observed in patients relapsed or refractory to prior venetoclax-based regimens Data featured in a poster presentation at the European Hematology Association (EHA) 2023 Hybrid Congress SOUTH SAN FRANCISCO, Calif., June 7, 2023 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced promising data from an analysis of the Phase 2 study evaluating REZLIDHIA® … Read more
CARLSBAD, Calif., June 6, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2028 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the … Read more
Lors de la session ASCO Developmental Therapeutics – Immunotherapy ,le Dr Howard Safran a présenté des données encourageantes sur l’étude de phase 1/2 de Dragonfly portant sur DF1001, un TriNKET® engageant le système immunitaire et ciblant HER2 chez des patients atteints de tumeurs solides à un stade avancé. WALTHAM, Massachusetts, 6 juin 2023 /PRNewswire/ — Dragonfly Therapeutics, … Read more
Large-Capacity Tabletop Freezer Expands Line of Controlled-Rate Freezers for Cell and Gene Therapies; Now Available for Order BOTHELL, Wash., June 6, 2023 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced … Read more
INT230-6 Induced T-Cell Receptor Signaling, Macrophage Markers, and IL-18 and B-Cell Receptor Signaling Data Was Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4, 2023 WESTPORT, Conn., June 6, 2023 /PRNewswire/ — Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based … Read more